PBE Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Full metrics table
| Category | US Equities - Industry Sector | Expense | 0.59% | Return% 1Y | 39.58% | Total Holdings | 31 | Perf Week | 2.94% | Volume | 13,274 |
| Asset Type | Equities (Stocks) | AUM | $431M | Return% 3Y | 21.56% | NAV | $99.29 | Perf Month | 1.94% | Avg Volume | 0.03M |
| ETF Type | US Equities | Dividend TTM | $1.33 (1.34%) | Return% 5Y | 6.65% | 52W High | -0.19% | Perf Quarter | 10.7% | Rel Volume | 0.46 |
| Active/Passive | Passive | Div Gr. 3/5Y | - 95.02% | Return% 10Y | 9.46% | 52W Low | 37.76% | Perf Half Y | 22.79% | Prev Close | $99.22 |
| IPO | 2005/6/23 | Flows% 1M | -0.45% | Return% SI | 9.63% | RSI (14) | 59.65 | Perf YTD | 21.19% | Price | $99.56 |
| Beta | 0.73 | Flows% 3M | 34.46% | Flows% YTD | 34.21% | Flows% 1Y | 34.97% | Perf Year | 35.71% | Volatility(W/M) | 1.82% 1.77% |
| SMA20 | 3.04% | SMA50 | 3.48% | SMA200 | 14.93% | ATR | 1.8 | ||||
Invesco Dynamic Biotechnology & Genome ETF seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
The top 10 make up 57% of the fund
REGN Regeneron Pharmaceuticals, Inc. 5.47% 3 
AMGN Amgen Inc. 5.22% 4 
CDNA CareDx, Inc. 5.04% 5 
VRTX Vertex Pharmaceuticals Inc. 4.99% 
RPRX Royalty Pharma PLC 4.94% 8 
BIIB Biogen Inc. 4.79% 9 
GILD Gilead Sciences, Inc. 4.43% 10 
UTHR United Therapeutics Corp. 4.08% Largest sectors first.
Over the past 1 year, on the higher side
0% below its 1-year high.
Traded less than usual. That is 46% of its average volume.
Holding long would have paid off
Bought 5 years ago, your return today would be +32.8%. The S&P 500 did +70% over the same period.
Tap to view numbers
The price swings a lot
At its worst (February 2021) it fell 38% and took 1261 days to recover.
Tap to view numbers
The dividend is on the small side
Pays 1.34% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 35.0% of assets came in.
Tap to view numbers
LABU Direxion Daily S&P Biotech Bull 3X ETF 643M 
MRNY YieldMax MRNA Option Income Strategy ETF 275M 
BIB ProShares Ultra Nasdaq Biotechnology 2X Shares 96M 
LABD-1× Direxion Daily S&P Biotech Bear 3X ETF 55M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
VFH Vanguard Financials ETF 0.09% 
ONEQ Fidelity Nasdaq Composite Index ETF 0.21% 
VIS Vanguard Industrials ETF 0.09% 
FV First Trust Dorsey Wright Focus 5 ETF 0.89% 
IYF iShares U.S. Financials ETF 0.37% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
FAQ
How many holdings does PBE have?
PBE holds a total of 31 securities, with an AUM of approximately $431M.
Does PBE pay dividends (distributions)?
PBE's distribution yield is approximately 1.34%.
What is the 52-week high and low for PBE?
PBE has recorded a 52-week high of $99.75 and a low of $72.27.
